ATLAS Biolabs certified for innovative exome enrichment technology from Roche NimbleGen
Berlin, March 29, 2011 – ATLAS Biolabs GmbH has become the second service provider in Europe to be certified for SeqCap EZ Exome and SeqCap EZ Choice enrichment technology from Roche NimbleGen. The new technology allows the targeted enrichment and subsequent sequencing of the human exome, i.e. of all genomic DNA sequences that carry the genetic blueprint encoding the body-s proteins. ATLAS Biolabs is thus expanding its range of services in the field of DNA enrichment. Only recently, the company